rs397518468
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_001134407.3(GRIN2A):c.1592C>T(p.Thr531Met) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T531T) has been classified as Likely benign.
Frequency
Consequence
NM_001134407.3 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- Landau-Kleffner syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- continuous spikes and waves during sleepInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutationInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- rolandic epilepsy-speech dyspraxia syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- self-limited epilepsy with centrotemporal spikesInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: G2P
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Landau-Kleffner syndrome Pathogenic:4
PM2_Supporting+PP2+PS4_Moderate+PP1+PP4+PM6_Supporting+PS3_Moderate -
- -
- -
This sequence change replaces threonine, which is neutral and polar, with methionine, which is neutral and non-polar, at codon 531 of the GRIN2A protein (p.Thr531Met). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of GRIN2A-related conditions (PMID: 23933818, 30544257; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 88730). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt GRIN2A protein function. Experimental studies have shown that this missense change affects GRIN2A function (PMID: 23933818, 27839871). For these reasons, this variant has been classified as Pathogenic. -
not provided Pathogenic:2
Identified in a family with epileptic encephalopathy with continuous spike and wave during slow wave sleep and intermediate epilepsy-aphasia disorder (Carvill et al., 2013); Published functional studies demonstrate a damaging effect (reduced protein level and lack of macroscopic current responses) (Swanger et al., 2016); Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28351718, 25921602, 25904555, 25498981, 30544257, 27839871, 33897753, 29455050, 23933818) -
GRIN2A: PS2, PM2, PS4:Moderate, PP2, PS3:Supporting -
Seizure Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at